Whole human genome sequences could soon cost as little as $1,000, but Cold Spring Harbor Laboratory's Gholson Lyon says that "the current biomedical research establishment is entirely unprepared for such a scenario." Here's why: "Researchers often believe that their mission is to uncover new biology and genetics, and that someone else will translate them to the clinical arena," he writes in a post at Project Syndicate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.